You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NMDA receptor positive allosteric modulator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

MDD Trial (GATE-251, Placebo)

Completed
  • Major Depressive Disorder
  • (no location specified)
Jul 28, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Not yet recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Sep 4, 2023

Bipolar Depression, MDD Trial in Chi?inau (Palmitoylethanolamide)

Recruiting
  • Bipolar Depression
  • Major Depressive Disorder
  • Chișinău, Moldova, Republic of
    State University of Medicine and Pharmacy " Nicolae Testemitsanu
Sep 26, 2023

MDD Trial in London (MIJ821)

Not yet recruiting
  • Major Depressive Disorder
  • London, United Kingdom
    Parexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

Not yet recruiting
  • Major Depressive Disorder (MDD)
  • HS-10353 30mg oral capsules
  • +3 more
  • (no location specified)
Jul 10, 2023

Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

Recruiting
  • Breast Cancer Recurrent
  • Palbociclib 125mg
  • Standard endocrine therapy
  • Graz, Austria
  • +52 more
Nov 15, 2022

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Essential Tremor Trial in United States (CAD-1883)

Completed
Has Results
  • Essential Tremor
  • Anniston, Alabama
  • +6 more
Jul 12, 2021

Cognitive Impairment Trial in Nashville (Single Dose of VU319, Single Dose Placebo, Fed State)

Completed
  • Cognitive Impairment
  • Single Dose of VU319
  • +5 more
  • Nashville, Tennessee
    Vanderbilt Medical Center
Feb 5, 2020

Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

Not yet recruiting
  • Preemptive Analgesia
  • +5 more
  • Kafr Ash Shaykh, Karelsheikh, Egypt
    Karelsheikh University Hospital
Apr 19, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

Bipolar I Disorder Trial (NMDAE, Placebo Cap)

Not yet recruiting
  • Bipolar I Disorder
  • (no location specified)
Aug 3, 2023

Inhibitory Neurotransmission in the Human Epileptic Brain.

Recruiting
  • Drug Resistant Epilepsy
  • ex-vivo study
  • Pozzilli, Isernia, Italy
    IRCCS INM Neuromed
Jul 29, 2022

Mental Disorder Trial in France (immunomodulatory treatment by rituximab)

Not yet recruiting
  • Mental Disorder
  • immunomodulatory treatment by rituximab
  • Bordeaux, France
  • +8 more
Jul 7, 2023

Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

Recruiting
  • Schizophrenia
  • +2 more
  • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
  • New Haven, Connecticut
    Connecticut Mental Health Center
Sep 16, 2022

Postoperative Shivering Trial in Islamabad (Dexmedetomidine, Ketamine)

Completed
  • Postoperative Shivering
  • Islamabad, Federal, Pakistan
    PAF Hospital Islamabad
Feb 6, 2023

Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())

Recruiting
  • Treatment Resistant Depression
  • +2 more
  • Ketamine Hydrochloride
  • No intervention (placebo)
  • Oxford, United Kingdom
    Department of Psychiatry, University of Oxford
Mar 28, 2023

Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

Suspended
  • Disorder of Consciousness
  • Traumatic Brain Injury
  • Amantadine + L-DOPA
  • NMDA blocker
  • New York, New York
    Weill Cornell Medicine
Sep 27, 2022

Solid Tumor Trial in Worldwide (BDTX-189)

Terminated
  • Solid Tumor
  • Scottsdale, Arizona
  • +37 more
Oct 13, 2022

Bipolar Depression, Suicidal Ideation Trial in New York (NRX-101, Lurasidone HCl, Placebo)

Completed
  • Bipolar Depression
  • Suicidal Ideation
  • New York, New York
    New York State Psychiatric Institute
Aug 5, 2022